Scandinavian ChemoTech AB (publ) Interim report Q1 January – March 2020 Executive Summary of the first quarter
First quarter · Net sales amounted to kSEK 90 (20) · Order intake amounted to kSEK 631 · The order book amounted to kSEK 1,125 at the end of the quarter · Profit before tax amounted to kSEK -3,464 (-2,579) · Earnings per share amounted to SEK -1.02 (-1.02) · Cash flow from operating activities totaled to kSEK -4,120 (- 3,711) Important events during the first quarter · Signed a loan agreement that secures financing of MSEK 4 from shareholders and investors · Signed a collaboration agreement for clini-cal validation and distribution with Femaug Logistics and